Perampanel
Brand name: Fycompa
Rank #374 of 500 drugs by total cost
$25.9M
Total Cost
20,876
Total Claims
$25.9M
Total Cost
788
Prescribers
$1,241
Cost per Claim
621
Beneficiaries
22,555
30-Day Fills
$33K
Avg Cost/Provider
26
Avg Claims/Provider
About Perampanel
Perampanel (sold as Fycompa) was prescribed 20,876 times by 788 Medicare Part D providers in 2023, costing the program $25.9M. At $1,241 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 371 | Brinzolamide/Brimonidine Tart (Simbrinza) | $26.3M | 97,240 |
| 372 | Rotigotine (Neupro) | $26.2M | 23,665 |
| 373 | Chlorpromazine Hcl (Chlorpromazine Hcl) | $25.9M | 78,710 |
| 374 | Perampanel (Fycompa) | $25.9M | 20,876 |
| 375 | Timolol Maleate (Timolol Maleate) | $25.8M | 1,129,537 |
| 376 | Amitriptyline Hcl (Amitriptyline Hcl) | $25.8M | 1,295,043 |
| 377 | Tezepelumab-Ekko (Tezspire) | $25.6M | 5,900 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology